AzTrials
AzTrials

SurgeryNCT05688722

Head Elevation During Pre-oxygenation Can Delay Desaturation Time

A study testing Supine position, 20 degree head elevation position and 30 degree head elevation position in people with Surgery and Desaturation of Blood, run by Universitas Indonesia at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is a randomized-controlled trial study comparing the association between several degree of head elevation and conventional position during pre-oxygenation to desaturation time in patients undergo endotracheal intubation with general anesthesia Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Surgery, Desaturation of Blood, Apnea
What is being tested?
Supine position, 20 degree head elevation position and 30 degree head elevation position
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
56 participants
Where
1 siteIndonesia
Study dates
1 Apr 2021to 31 May 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • undergo endotracheal intubation with general anesthesia for elective surgery
  • aged 18-60 years old
  • ASA physical status 1-2 preoperatively

Who cannot join

  • Patients with difficult airway, cardiopulmonary disease, anemia, grade II obesity, pregnant, history of hypersensitivity to induction agents
  • Patients did not give consent to follow the study

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Cipto Mangunkusumo Central National Hospital

    Jakarta Pusat, DKI Jakarta, 10430

Other trials in Indonesia

About this study

Official title: Head Elevation During Pre-oxygenation Can Delay Desaturation Time in Indonesian Patients

This study is a randomized-controlled trial study comparing the association between several degree of head elevation and conventional position during pre-oxygenation to desaturation time in patients undergo endotracheal intubation with general anesthesia

Read the detailed description

Preoxygenation anesthesia induction is an important part of airway management to reduce the risk of hypoxemia when the patient is apneic. The effectivity of preoxygenation is influenced by several things such as patient's head position. This study aimed to compare preoxygenation with head elevation 20°, 30° and 45° and conventional position to the time of desaturation before endotracheal intubation in patients undergoing general anesthesia. This was a randomized clinical trial of 56 patients, divided into four groups (conventional or 0° head elevation group, 20° head elevation group, 30° head elevation and 45° head elevation group). All subject was preoxygenated for 3 minutes with 100% oxygen. Induction of anesthesia was started with fentanyl, propofol, followed by rocuronium after the patient lost consciousness. Time was recorded from the start of induction until the oxygen saturation showed 93% or a time limit of 5 minutes. There was a significant difference in mean desaturation time among the four groups (p = 0.011). The most significant different was in 45o head elevation group (p < 0.05). . In patients undergoing general anesthesia, pre-oxygenation with head elevation 20°, 30° and 45° slows down the time for desaturation before endotracheal intubation compared to the conventional position. The 45° head elevation has the best result.

Being tested
Supine position, 20 degree head elevation position, 30 degree head elevation position, 45 degree head elevation position
Keywords
preoxygenation, head elevation, desaturation, apnea
Medical subject headings
Apnea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Supine positionProcedure or surgery

    Patients preoxygenated in supine position before endotracheal intubation

  • 20 degree head elevation positionProcedure or surgery

    Patients preoxygenated in 20 degree head elevation position before endotracheal intubation

  • 30 degree head elevation positionProcedure or surgery

    Patients preoxygenated in 30 degree head elevation position before endotracheal intubation

  • 45 degree head elevation positionProcedure or surgery

    Patients preoxygenated in 45 degree head elevation position before endotracheal intubation

Study groups in NCT05688722
Study groupRoleWhat they receive
ControlPlacebo comparatorPatient positioned in supine conventional position
Receives: Procedure: Supine position
20 degree head elevationActive comparatorPatient positioned in 20 degree head elevation position
Receives: Procedure: 20 degree head elevation position
30 degree head elevationActive comparatorPatient positioned in 30 degree head elevation position
Receives: Procedure: 30 degree head elevation position
45 degree head elevationActive comparatorPatient positioned in 45 degree head elevation position
Receives: Procedure: 45 degree head elevation position

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Desaturation time

    Time was recorded from the start of induction until the oxygen saturation showed 93% or a time limit of 5 minutes

    Measured: Right after induction until reach oxygen saturation 93% or 5 minutes time limit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2023
  2. Study start1 Apr 2021
  3. Primary completion31 May 2021
  4. Study completion31 May 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients were divided into 4 groups by random sampling each with different intervention
Masking
Single blind
Who is masked
Participant
Enrolment
56 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05688722
Sponsor's protocol ID
IndonesiaUAnes913
Status last verified
Jan 2023
First submitted
9 Jan 2023
Last updated
18 Jan 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Supine position, 20 degree head elevation position and 30 degree head elevation position in people with Surgery and Desaturation of Blood, run by Universitas Indonesia at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Desaturation time (time frame: Right after induction until reach oxygen saturation 93% or 5 minutes time limit). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2023; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in